These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 12473203)
1. Functional tolerance of Streptomyces subtilisin inhibitor toward conformational and stability changes caused by single-point mutations in the hydrophobic core. Oda M; Tamura A; Kanaori K; Kojima S; Miura K; Momma K; Tonomura B; Akasaka K J Biochem; 2002 Dec; 132(6):991-5. PubMed ID: 12473203 [TBL] [Abstract][Full Text] [Related]
2. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae. Terabe M; Kojima S; Taguchi S; Momose H; Miura K Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578 [TBL] [Abstract][Full Text] [Related]
3. A thermodynamic study of mutant forms of Streptomyces subtilisin inhibitor. I. Hydrophobic replacements at the position of Met103. Tamura A; Sturtevant JM J Mol Biol; 1995 Jun; 249(3):625-35. PubMed ID: 7783215 [TBL] [Abstract][Full Text] [Related]
4. Effect of inhibitory activity of mutation at reaction site P4 of the Streptomyces subtilisin inhibitor, SSI. Kojima S; Kumagai I; Miura K Protein Eng; 1990 May; 3(6):527-30. PubMed ID: 2196560 [TBL] [Abstract][Full Text] [Related]
5. Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action. Kojima S; Kumagai I; Miura K J Mol Biol; 1993 Mar; 230(2):395-9. PubMed ID: 8464055 [TBL] [Abstract][Full Text] [Related]
6. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor. Hipler K; Priestle JP; Rahuel J; Grütter MG Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309 [TBL] [Abstract][Full Text] [Related]
7. A protease inhibitor produced by Streptomyces lividans 66 exhibits inhibitory activities toward both subtilisin BPN' and trypsin. Ueda Y; Kojima S; Tsumoto K; Takeda S; Miura K; Kumagai I J Biochem; 1992 Aug; 112(2):204-11. PubMed ID: 1356971 [TBL] [Abstract][Full Text] [Related]
8. A thermodynamic study of mutant forms of Streptomyces subtilisin inhibitor. III. Replacements of a hyper-exposed residue, Met73. Tamura A; Sturtevant JM J Mol Biol; 1995 Jun; 249(3):646-53. PubMed ID: 7783217 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of temporary inhibition in Streptomyces subtilisin inhibitor induced by an amino acid substitution, tryptophan 86 replaced by histidine. Tamura A; Kanaori K; Kojima S; Kumagai I; Miura K; Akasaka K Biochemistry; 1991 May; 30(21):5275-86. PubMed ID: 2036394 [TBL] [Abstract][Full Text] [Related]
10. Stabilized variant of Streptomyces subtilisin inhibitor and its use in stabilizing subtilisin BPN'. Ganz PJ; Bauer MD; Sun Y; Fieno AM; Grant RA; Correa PE; Laskowski M; Saunders CW Protein Eng Des Sel; 2004 Apr; 17(4):333-9. PubMed ID: 15187224 [TBL] [Abstract][Full Text] [Related]
11. Contribution of salt bridge in the protease inhibitor SSI (Streptomyces subtilisin inhibitor) to its inhibitory action. Kojima S; Fujimura K; Kumagai I; Miura K FEBS Lett; 1994 Jan; 337(2):195-9. PubMed ID: 8287976 [TBL] [Abstract][Full Text] [Related]
12. Long-range dynamic effects of point mutations propagate through side chains in the serine protease inhibitor eglin c. Clarkson MW; Lee AL Biochemistry; 2004 Oct; 43(39):12448-58. PubMed ID: 15449934 [TBL] [Abstract][Full Text] [Related]
13. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures. Krystek S; Stouch T; Novotny J J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666 [TBL] [Abstract][Full Text] [Related]
14. Alteration of the specificity of the Streptomyces subtilisin inhibitor by gene engineering. Kojima S; Obata S; Kumagai I; Miura K Biotechnology (N Y); 1990 May; 8(5):449-52. PubMed ID: 1366538 [TBL] [Abstract][Full Text] [Related]
15. Secondary structures and structural fluctuation in a dimeric protein, Streptomyces subtilisin inhibitor. Sasakawa H; Tamura A; Fujimaki S; Taguchi S; Akasaka K J Biochem; 1999 Nov; 126(5):859-65. PubMed ID: 10544278 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor. Kojima S; Nishiyama Y; Kumagai I; Miura K J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859 [TBL] [Abstract][Full Text] [Related]
17. A thermodynamic study of mutant forms of Streptomyces subtilisin inhibitor. II. Replacements at the interface of dimer formation, Val13. Tamura A; Kojima S; Miura K; Sturtevant JM J Mol Biol; 1995 Jun; 249(3):636-45. PubMed ID: 7783216 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond. Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146 [TBL] [Abstract][Full Text] [Related]
19. Molecular phylogenetic characterization of Streptomyces protease inhibitor family. Taguchi S; Kojima S; Terabe M; Kumazawa Y; Kohriyama H; Suzuki M; Miura K; Momose H J Mol Evol; 1997 May; 44(5):542-51. PubMed ID: 9115178 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a protein proteinase inhibitor, Streptomyces subtilisin inhibitor, at 2.3 angstrom resolution. Mitsui Y; Satow Y; Sakamaki T; Iitaka Y J Biochem; 1977 Jul; 82(1):295-8. PubMed ID: 893385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]